These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 7522742)

  • 1. Inactivation of E2a in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosis.
    Yang Y; Nunes FA; Berencsi K; Gönczöl E; Engelhardt JF; Wilson JM
    Nat Genet; 1994 Jul; 7(3):362-9. PubMed ID: 7522742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolonged transgene expression in cotton rat lung with recombinant adenoviruses defective in E2a.
    Engelhardt JF; Litzky L; Wilson JM
    Hum Gene Ther; 1994 Oct; 5(10):1217-29. PubMed ID: 7849095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistence of replication-deficient adenovirus-mediated gene transfer in lungs of immune-deficient (nu/nu) mice.
    Zsengeller ZK; Wert SE; Hull WM; Hu X; Yei S; Trapnell BC; Whitsett JA
    Hum Gene Ther; 1995 Apr; 6(4):457-67. PubMed ID: 7612702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transfer of the CFTR gene to the lung of nonhuman primates with E1-deleted, E2a-defective recombinant adenoviruses: a preclinical toxicology study.
    Goldman MJ; Litzky LA; Engelhardt JF; Wilson JM
    Hum Gene Ther; 1995 Jul; 6(7):839-51. PubMed ID: 7578403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct gene transfer of human CFTR into human bronchial epithelia of xenografts with E1-deleted adenoviruses.
    Engelhardt JF; Yang Y; Stratford-Perricaudet LD; Allen ED; Kozarsky K; Perricaudet M; Yankaskas JR; Wilson JM
    Nat Genet; 1993 May; 4(1):27-34. PubMed ID: 7685651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic analysis of repeated gene delivery into animal lungs with a recombinant adenovirus vector.
    Dong JY; Wang D; Van Ginkel FW; Pascual DW; Frizzell RA
    Hum Gene Ther; 1996 Feb; 7(3):319-31. PubMed ID: 8835219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant adenovirus deleted of all viral genes for gene therapy of cystic fibrosis.
    Fisher KJ; Choi H; Burda J; Chen SJ; Wilson JM
    Virology; 1996 Mar; 217(1):11-22. PubMed ID: 8599194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene therapy of cystic fibrosis lung disease using E1 deleted adenoviruses: a phase I trial.
    Wilson JM; Engelhardt JF; Grossman M; Simon RH; Yang Y
    Hum Gene Ther; 1994 Apr; 5(4):501-19. PubMed ID: 7519452
    [No Abstract]   [Full Text] [Related]  

  • 9. Gene therapy for cystic fibrosis using E1-deleted adenovirus: a phase I trial in the nasal cavity. The University of North Carolina at Chapel Hill.
    Boucher RC; Knowles MR; Johnson LG; Olsen JC; Pickles R; Wilson JM; Engelhardt J; Yang Y; Grossman M
    Hum Gene Ther; 1994 May; 5(5):615-39. PubMed ID: 7519885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety of adenovirus-mediated transfer of the human cystic fibrosis transmembrane conductance regulator cDNA to the lungs of nonhuman primates.
    Wilmott RW; Amin RS; Perez CR; Wert SE; Keller G; Boivin GP; Hirsch R; De Inocencio J; Lu P; Reising SF; Yei S; Whitsett JA; Trapnell BC
    Hum Gene Ther; 1996 Feb; 7(3):301-18. PubMed ID: 8835218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute responses of non-human primates to airway delivery of an adenovirus vector containing the human cystic fibrosis transmembrane conductance regulator cDNA.
    Brody SL; Metzger M; Danel C; Rosenfeld MA; Crystal RG
    Hum Gene Ther; 1994 Jul; 5(7):821-36. PubMed ID: 7526901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver.
    Engelhardt JF; Ye X; Doranz B; Wilson JM
    Proc Natl Acad Sci U S A; 1994 Jun; 91(13):6196-200. PubMed ID: 8016137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the respiratory epithelium of normals and individuals with cystic fibrosis for the presence of adenovirus E1a sequences relevant to the use of E1a- adenovirus vectors for gene therapy for the respiratory manifestations of cystic fibrosis.
    Eissa NT; Chu CS; Danel C; Crystal RG
    Hum Gene Ther; 1994 Sep; 5(9):1105-14. PubMed ID: 7833370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy.
    Yang Y; Nunes FA; Berencsi K; Furth EE; Gönczöl E; Wilson JM
    Proc Natl Acad Sci U S A; 1994 May; 91(10):4407-11. PubMed ID: 8183921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct in vivo gene transfer and expression in malignant cells using adenovirus vectors.
    Brody SL; Jaffe HA; Han SK; Wersto RP; Crystal RG
    Hum Gene Ther; 1994 Apr; 5(4):437-47. PubMed ID: 7519451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and analysis of recombinant adenoviruses for gene therapy of cystic fibrosis.
    Rich DP; Couture LA; Cardoza LM; Guiggio VM; Armentano D; Espino PC; Hehir K; Welsh MJ; Smith AE; Gregory RJ
    Hum Gene Ther; 1993 Aug; 4(4):461-76. PubMed ID: 7691187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trans-complementation of E1-deleted adenovirus: a new vector to reduce the possibility of codissemination of wild-type and recombinant adenoviruses.
    Imler JL; Bout A; Dreyer D; Dieterlé A; Schultz H; Valerio D; Mehtali M; Pavirani A
    Hum Gene Ther; 1995 Jun; 6(6):711-21. PubMed ID: 7548271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo biology of recombinant adenovirus vectors with E1, E1/E2A, or E1/E4 deleted.
    Lusky M; Christ M; Rittner K; Dieterle A; Dreyer D; Mourot B; Schultz H; Stoeckel F; Pavirani A; Mehtali M
    J Virol; 1998 Mar; 72(3):2022-32. PubMed ID: 9499056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective gene transfer into the liver of non-human primates with E1-deleted, E2A-defective, or E1-E4 deleted recombinant adenoviruses.
    Raper SE; Haskal ZJ; Ye X; Pugh C; Furth EE; Gao GP; Wilson JM
    Hum Gene Ther; 1998 Mar; 9(5):671-9. PubMed ID: 9551615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenovirus-mediated gene transfer for cystic fibrosis: quantitative evaluation of repeated in vivo vector administration to the lung.
    Yei S; Mittereder N; Tang K; O'Sullivan C; Trapnell BC
    Gene Ther; 1994 May; 1(3):192-200. PubMed ID: 7584081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.